Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves

NCT01939366 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

699

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pain
Diabetic Neuropathies
Diabetes Mellitus

Interventions

DRUG: Cebranopadol 100 µg
DRUG: Cebranopadol 300 µg
DRUG: Cebranopadol 600 µg
DRUG: Pregabalin
DRUG: Matching Placebo

Sponsor

Tris Pharma, Inc.